Full Text View
Tabular View
No Study Results Posted
Related Studies
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by Julius-Maximilians University.
Recruitment status was  Recruiting
Study NCT00108875   Information provided by Julius-Maximilians University

First Received on April 19, 2005.   Last Updated on July 27, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malignant Melanoma
Pancreatic Cancer
Colon Cancer
Cervical Cancer
Additional conditions recognized in this trial
Colonic Neoplasms
Melanoma
Pancreatic Neoplasms
Uterine Cervical Neoplasms
More general conditions related to this trial
Colonic Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Genital Diseases, Female
Genital Neoplasms, Female
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Pancreatic Diseases
Urogenital Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
Survivin peptide vaccine
Sponsors listed in this trial
Julius-Maximilians University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services